In conclusion, this study demonstrates the feasibility of delivering microencapsulated oleic acid to the distal intestine to treat chronic constipation in patients treated for obesity with bariatric surgery and/or GLP-1 analogues, without safety concerns. This evidence concerns the gene GCG and obesity disorder.